Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $55

Benzinga Newsdesk www.benzinga.com Negative 68.4%

Neg 68.4% Neu 0% Pos 0%

Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $58 to $55.